找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Resistant Hypertension; Massimo Salvetti Book 2016 Springer International Publishing Switzerland 2016 Difficult-to-treat hypertension.Fals

[復(fù)制鏈接]
樓主: 懇求
11#
發(fā)表于 2025-3-23 10:43:41 | 只看該作者
12#
發(fā)表于 2025-3-23 14:05:25 | 只看該作者
13#
發(fā)表于 2025-3-23 21:32:03 | 只看該作者
14#
發(fā)表于 2025-3-24 00:55:19 | 只看該作者
Adult Patient with Pseudo-Resistant Hypertension: Spurious Resistant Hypertension,ue resistance to treatment. In fact, studies have shown that up to one third of patients with suspected resistant hypertension have normal 24-h (or home) blood pressure values and that these patients have much less organ damage and a better prognosis as compared to “true resistant” hypertensives.
15#
發(fā)表于 2025-3-24 05:02:44 | 只看該作者
16#
發(fā)表于 2025-3-24 10:21:20 | 只看該作者
Adult Patient with Pseudo-Resistant Hypertension: High Blood Pressure Induced by Exogenous Substancfactors responsible for poor BP control. In these patients, after the assessment of adherence to lifestyle measures and to drug treatment, the diagnostic workup should include the evaluation of possible secondary forms of hypertension. An accurate evaluation of the drugs and substances assumed by th
17#
發(fā)表于 2025-3-24 12:51:17 | 只看該作者
18#
發(fā)表于 2025-3-24 16:35:13 | 只看該作者
Adult Patient with Pseudo-Resistant Hypertension: Drug Intolerance,ved. Today, several classes of effective antihypertensive drugs are available, and in particular ACE inhibitors, angiotensin II receptor blockers, calcium antagonists, diuretics and beta blockers are all considered first-line drugs by current European Guidelines; furthermore, other molecules may be
19#
發(fā)表于 2025-3-24 21:38:02 | 只看該作者
20#
發(fā)表于 2025-3-25 02:12:33 | 只看該作者
Adult Patient with Resistant Hypertension Secondary to Comorbidities,ic. Lifestyle was certainly not optimal in this obese patient. Obesity and overweight are quite common in patients with BP elevation, being present in about 75?% of the hypertensive patients seen by general practitioners or specialists. Together with combination treatment with antihypertensive drugs
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 18:51
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
保靖县| 成安县| 荣昌县| 长泰县| 高台县| 三穗县| 沈阳市| 洪湖市| 长顺县| 康保县| 云浮市| 英山县| 郴州市| 新兴县| 武穴市| 神农架林区| 大姚县| 苗栗县| 新龙县| 隆昌县| 鹤庆县| 枞阳县| 迭部县| 慈溪市| 大邑县| 萍乡市| 衡阳市| 搜索| 宜君县| 信宜市| 河间市| 荆州市| 普安县| 邳州市| 江油市| 岑溪市| 天门市| 长垣县| 易门县| 乌鲁木齐市| 专栏|